- Report
- September 2024
- 200 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Book
- April 2020
- 448 Pages
- Book
- February 2025
- 496 Pages
Haemoglobinopathies are genetic disorders that affect the production of haemoglobin, the protein in red blood cells that carries oxygen throughout the body. These disorders can cause a range of symptoms, including anaemia, fatigue, and jaundice. Coagulation and hemostasis testing is used to diagnose haemoglobinopathies, as well as to monitor the effectiveness of treatments. Tests measure the levels of haemoglobin, haemoglobin variants, and other proteins in the blood.
The haemoglobinopathies market is a subset of the larger coagulation and hemostasis testing market. It is composed of a range of products, including reagents, instruments, and software. These products are used to diagnose and monitor haemoglobinopathies, as well as to develop new treatments.
Some companies in the haemoglobinopathies market include Abbott, Siemens Healthineers, Ortho Clinical Diagnostics, Bio-Rad Laboratories, and Roche Diagnostics. Show Less Read more